MindMed

MindMed discovers, develops, and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering.

*IPO March 2020*

INDUSTRY
BIOTECHNOLOGY

OUR ROLE
ANGEL INVESTOR

SINCE
AUGUST 2019

BASED IN
NEW YORK, NY